Docetaxel (Taxotere) : a new option for the treatment of hormone-refractory prostate cancer
Card's contents:DOCETAXEL 312.461 Docetaxel (Taxotere) : a new option for the treatment of hormone-refractory prostate cancer / Nicholas J. Vogelzang, guest ed. ; contributors Emilia Bagiella [et al.]. - Philadelphia : W.B. Saunders Co. a Division of Harcourt Brace and Co., 1999. - [6], 68 s. ; 28 cm. - (Seminars in Oncology, ISSN 0093-7754 ; vol. 26, suppl. 17) Bibliogr. przy art